AstraZeneca Reaffirms Commitment To Cancer Care

AstraZeneca reaffirms commitment to cancer care on World Cancer Day 2025 with innovative solutions
JOHANNESBURG: In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative
Africa: Astrazeneca Reaffirms Commitment to Cancer Care On World Cancer Day
AstraZeneca has reinforced its commitment to advancing cancer care through early detection, innovative treatments, and equitable healthcare access in recognition of World Cancer Day 2025 under the theme 'United by Unique.
AstraZeneca strengthens cancer care in Africa with innovative early detection and treatment initiatives
AstraZeneca has reaffirmed its commitment to transforming cancer care in Africa, unveiling new initiatives aimed at enhancing early detection, treatment, and patient support as part of World Cancer Day 2025.
NHS to be ‘United by Unique’ innovation in more people-centred care on World Cancer Day
World Cancer Day is an opportunity to inspire Scotland’s diverse healthcare innovators to unite for patient equity in the fight against the country’s leading cause of death, says an NHS partner.
This World Cancer Day, Pledge To Break Barriers In Cancer Care
F ebruary 4 marks World Cancer Day, a global movement that seeks to mobilise individuals, communities, and governments to take action against cancer by raising awareness and promo
The Star19h
AstraZeneca to introduce advanced lung cancer testing in Kenya
Biopharmaceutical giant AstraZeneca has announced it is introducing advanced diagnostic testing for lung cancer in Kenya and ...
FiercePharma15h
World Cancer Day 2025: Merck, Pfizer, GSK among pharmas raising awareness of prevention, detection, treatment options
In 2000, the Union for International Cancer Control (UICC) named Feb. | In 2000, the Union for International Cancer Control named Feb. 4 World Cancer Day, with a goal of raising awareness of cancer ...
EuropaWire17h
AstraZeneca’s Imfinzi Recommended for EU Approval as Breakthrough Treatment for Limited-Stage Small Cell Lung Cancer
AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...